Search clinical trials for: CCT3833

Total 2 results

Royal Marsden NHS Foundation Trust
Wellcome Trust; Institute of Cancer Research, United Kingdom; Biomedical Research...

Completed

A Phase I, First in Man Study to Evaluate the Safety and Tolerability of a panRAF Inhibitor (CCT3833/BAL3833)in Patients With Solid Tumours (PanRAF)

Melanoma | Cancer

United Kingdom
Shanghai PerHum Therapeutics Co., Ltd.
Shanghai Zhongshan Hospital

Recruiting

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Sarcoma | Breast Cancer | Gastric Cancer | Ovarian Cancer | Solid Tumor

China

3

Subscribe